SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets
CTG 8.360-1.4%11:52 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: richardred9/24/2012 10:47:18 AM
  Read Replies (1) of 6273
 
New risky buy today. PTIE-Pain Therapeutics. IMO a lot of the wind has already been taken out of its sails for an earlier non FDA approval. Based on the hopes Pfizer can get FDA approval of REMOXY within 6 months.

I owned this one before and sold after the deal with King Pharmaceuticals lifted the stock. Pfizer bought King and the those rights. IMO the pain market with a harder to abuse pain killer is something the FDA can only ignore for so long. Purdue Frederick Company's market share is there for the taking if approved.
Message 26881747
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext